Press release
Good Growth Opportunities in Global Virology Market Till 2025
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially issued a warning about the possible spread of zika virus to each Western Hemispheric region, as the disease vector Aedes aegypti was found to thrive strong in tropical and sub-tropical climatic conditions. This has been a key driver of market growth throughout 2016.
The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector; however, several diseases continue to demand R&D of novel applications, driving the growth of virology market. Various treatments and diagnostic processes also employ virology applications, further fuelling the market growth.
Burgeoning applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology is another factor fostering the overall growth of the virology market.
Moreover, the field of virology is extending in various forms, including molecular virology, paediatric virology, computational virology, and many more, prompting at increasing research findings throughout the forecast period. Research prospects are high and FMI indicates a continuing need for trained virologists in the near future.
Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market.
Key Restraints to Market Growth
Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.
Current Trends in the Virology Field
In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future.
Virologists are persistently investigating novel applications for viruses. Currently, an ongoing research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.
Global Virology Market: Competitive Landscape
By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1150
Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.
Virology Market: Segmentation
FMI's research on the global virology market provides a 10-year forecast, segmenting the market on the basis of product type, application, end-use, and region.
Based on product type, the global virology market is segmented into
Diagnosing Test
DNA Viruses
RNA Viruses
Prions Diagnostic Test
Other Viral Tests
Viral Infection Controlling Methods
Immunoprophylaxis
Active Prophylaxis (Vaccines)
Passive Prophylaxis
Antiviral Chemotherapy
Virucidal Agents
Antiviral Agents
Immunomodulators
Interferons
Cytokines
Based on application, the global virology market is segmented into
Skin and Soft Tissue Infections
Respiratory Tract Infections
GI Tract Infections
Urinary Tract Infections
Eye Infections
CNS Infections
Sexually Transmitted Diseases
Perinatal Infections
According to the end-user, the market is segmented into
Hospitals
Clinics
Laboratories
Diagnostic Centres
Blood Banks
Pharmacies
Regional Outlook: Global Virology Market
North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.
Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.
Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.
Segment-wise Market Forecast
Immunoprophylaxis therapy and antiviral drugs are the fastest-growing market segments in the estimated forecast period.
STDs, urinary tract infections, and respiratory tract infections are currently dominating compared to other application types in the global virology market.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1150
On the basis of diagnosis tests, hepatitis B, hepatitis C, HIV, human papillomavirus (HPV), and other tests (influenza, ebola, and dengue) are estimated to attract the largest market shares globally.
Hospitals and laboratories projected to continue the most dominating end-use segments, accounting for almost 50% market share globally.
Key Players in the Global Virology Market
The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.
Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Good Growth Opportunities in Global Virology Market Till 2025 here
News-ID: 457337 • Views: 365
More Releases from Future Market Insights
The German Tortilla Mix Market is estimated to grow at a CAGR of 4.7% by 2023 to …
In 2023, the market share of tortilla mix was estimated to be worth US$ 12.23 billion. By 2033, it was estimated to be worth US$ 23.18 billion. This is expected to further boost the market share of the tortilla mix and generate a CAGR of 6.6%.
The nutritional benefits of tortillas have become increasingly popular in both developed and developing countries. At the same time, a growing number of people are…
Asian pacific Sheep Shearing Equipment Market was valued at US$ 91.4 Million by …
The global sheep shearing equipment market was valued at US$ 755.8 Mn in 2022. The market is expected to develop from US$ 780 Mn in 2023 to US$ 1,069 Mn by 2033, registering a CAGR of 3.2% over the forecast period.
Shearing machinery is used on farms to cut or remove wool from sheep's bodies. The exceptional qualities of this equipment have increased demand. The need for sheep shearing equipment is growing since regular shearing is necessary to keep…
The UK Stock Tank Market was valued at US$ 499.2 Million by the time of 2033
A CAGR of 6.5% is predicted for the global stock tank market over the forecast period. The market is anticipated to increase from US$ 2.82 Bn in 2023 to US$ 5.30 Bn by 2033.
The stock tank business has recently seen tremendous demand. The summer has grown more challenging for both humans and animals due to global warming. To save the farm animals and combat the heat, farms are installing stock tank pools significantly.
Increasing demands for increased…
By 2032, the Egg Albumin Protein Market is expected to be worth US$ 2.88 Billion
According to a recent report published by Future Market Insights, sales of egg albumin protein are estimated to reach a valuation of US$ 2.88 Bn by 2032, surging at 7.3% CAGR during the forecast period of 2022 to 2032.
Egg albumin protein is absorbed by the blood and is used to separate proteins. It is expected to gain high popularity across the globe, especially in the sports nutrition sector owing to its ability…
More Releases for Virology
Virology Market: Technological Innovations & Market Insights till 2030
The study of Virology Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also this…
Virology Market Opportunities, Demand and Forecasts, 2015-2025
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…
11th International Virology and Infectious Diseases Congress
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
11th International Virology and Infectious Diseases Congress is a global platform to discuss and learn about Viral infections, Molecular biology, Epidemiology, Monoclonal antibodies, Virology Research, Viro therapy, Pediatric Infectious Diseases, Urinary…
11th International Virology and Infectious Diseases Congress
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Conference Series invites all the participants from all over the world to attend Virology Congress Conference which is to be held during July 27th -28th, 2018 Vancouver, Canada which includes prompt keynote…
A recent study offers insight about the Virology Market
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…
Virology Market To Increase at Steady Growth Rate
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Early in 2016, the WHO officially…
